Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Buying on dips..big influx ahead

<< Previous

Bullboard Posts

Next >>

Post by canadafanon Dec 02, 2022 10:22am

396 Views

Post# 35146188

Buying on dips..big influx ahead

Now, I can not prove. However I have heard there is a larger sized international $$$ pool, looking for an opportunity.
They have eyes on Onc.
should the jump in, the movement will be significant.
No I won't reveal my source. Actually, I won't even know if they are in or not.
just know th3 FDA fast track has gained a lot of attention.
Todays early dip?
on the heals of a 20% one day increase. Some are grabbing profits.
fundamentally, nothing has changed. They have Two paths to phase 3 registration.
more to come next week.